Study on drug-induced inner ear disorders caused by anti-cancer agents

Study on drug-induced inner ear disorders caused by anti-cancer agents - Study on drug-induced inner ear disorders

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000040491

Enrollment

Registered

2020-06-01

Start date

2019-11-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and neck cancer

Interventions

Perform audiometry and video Head Impulse Test on patients undergoing chemotherapy.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients over the age of 20 who are diagnosed with head and neck cancer and plan to undergo chemotherapy

Exclusion criteria

Exclusion criteria: Patients with cervical spine disease, reduced neck mobility, pain and neurological symptoms Patients who the investigator determined to be unsuitable for this study

Design outcomes

Primary

Measure	Time frame
Hearing level and vHIT gain values 1,4,7,12,24 weeks after the first dose of anticancer drug	—

Secondary

Measure	Time frame
Creatinine clearance value 1,4,7,12,24 weeks after the first administration of anticancer drug	—

Countries

Japan

Contacts

Public ContactSatoshi Takahashi

Kagawa University, Faculty of Medicine Otolaryngology

takahashi.satoshi.1x@kagawa-u.ac.jp087-891-2214

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026